echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Heart: infectious endocarditis concurrent pus-convulsive spinalitis

    Heart: infectious endocarditis concurrent pus-convulsive spinalitis

    • Last Update: 2020-06-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, a study published in Heart, the leading journal of cardiology, focused on assessing the characteristics and prognosis of infectious endocarditis (IE) patients with purulent spinalitis (PS)The secondary purpose is to assess the factors associated with the occurrence of PSresearchers conducted a case-control double-center study of 1,755 patients with PS (n-150) or ps (n-1605)The researchers recorded clinical, microbial and prognostoclist variables for the subjectsPS patients are older (average age is 69.7 x 18 vs66.2 x 14; p-0.004), and arterial hypertension (48% vs34.5% ;p 0.001) and autoimmune diseases (5% vs.2%; p-0.03) have more patients than patients with out of THE PSLumbar vertebrae are most frequently affected (84 patients, accounting for 66%), especially L4-L5Neurological symptoms were observed in 59% of patientsThe incidence of enterococci and thropomic streptococcus was higher in PS patients (24% vs12% and 24% vs11% ;p .0001)The diagnosis of PS in 92 patients was based on contrast-enhanced MRI, 88 patients were based on bone CT and 56 patients were based on 18F-FDG PET/CTThere was no difference between in-hospital mortality (16% vs13.5%, p-0.38) and 1 year mortality (21% vs22%, p-0.82) in patients with or without PS it was followed that PS was a common complication of IE (8.5% of IE) and was observed in patients with high blood pressure combined with enterococci or thropomic streptococcus IE, with a prognosis similar to other forms of IE Because PS is associated with specific treatments, multimodal imaging checks including MRI, CT, and PET/CT should be used to diagnose this complication of endocarditis at an early stage
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.